Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5665
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Functional study of voltagegated calcium channel gene mutations in schizophrenia using induced pluripotent stem cells (iPSCs): A new approach for developing a cellular model | Dr. Dhanjit Kumar Das, Scientist, National Institute for Research in Reproductive Health, Mumbai, Maharashtra | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Induced pluripotent stem cells (iPSCs) |
| Pharamacogenetic determinants of 6-mercaptopurine toxicity and relapse in children with acute lymphoblastic leukemia | Dr. Patchva Dorababu,Assistant Professor, Dept. of Pharmacology, Apollo Institute of Medical Science and Research, Hyderabad, Telangana | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Lymphoblastic leukemia |
| Design of bromodomain inhibitors for its anticancer activity | Dr. Giles D, Professor, Acharya & B M Reddy College of Pharmacy, Bengaluru, Karnataka | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Bromodomain inhibitors |
| Immunophenotypic profile of tumour infiltrating cells of the immune system & expression of PDL1 in triple negative/Her-2 neu positive breast cancer patients and their correlation with response to neoadjuvant chemotherapy | Dr. Sandeep Rajinder Mathur, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Triple negative/Her-2 neu positive breast cancer |
| Design, synthesis and biological evaluation of HDAC3 selective inhibitors as long term memory enhancers | Dr. Balaram Ghosh, Scientist, Birla Institute of Technology and Science (BITS), Pilani, Hyderabad, Telangana | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | HDAC3 selective inhibitors |
| Role of negative co-stimulatory molecule V-set domaincontaining T-cell activation inhibitor-1 (VTCN1) in vitiligo pathogenesis | Dr. Rasheedunnisa Begum, Professor, Department of Biochemistry, M S University of Baroda, Vadodara, Gujarat | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Vitiligo pathogenesis |
| A proteomic investigation to outline the mechanism associated to non response to corticosteroids therapy in patients with severe alcoholic hepatitis | Dr. Jaswinder Singh Maras, Inspire Faculty, Institute of Liver & Billary Sciences (ILBS), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Alcoholic hepatitis |
| Targeted next generation sequencing (NGS) for evaluating PI3/AKT/mTOR pathway as a potential therapeutic target for triple negative breast cancer | Dr. Amanjit Bal, Professor, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Triple negative breast cancer |
| Investigations of the antimitotic property of sulfamethoxazole (SMX) group of drugs: Mechanistic actions and relevance as a lead anticancer compound | Dr. Suvroma Gupta, Professor, Haldia Institute of Technology, Haldia, West Bengal | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Sulfamethoxazole (SMX) drugs |
| Role of sterile inflammation in accelerated skin carcinogenesis induced by in utero arsenic exposure | Dr. Vikas Srivastava, Scientist, Indian Institute of Toxicology Research (IITR), Lucknow, Uttar Pradesh | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Skin carcinogenesis |